Status: Not yet recruiting
Evaluation of XYA02 in Patients With Advanced Solid Tumors
This study will evaluate the safety, tolerability, and efficacy of XYA02 in participants with advanced solid tumors.
Participants needed: 190
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: XYone Therapeutics, IncUpdated: Jul 13, 2026Locations: 5
Eligibility criteria
Signed informed consent form(s) (ICFs) obtained at Screening. [+13]
Has been refractory (did not have a tumor response) to previous treatment with a... [+13]